Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Flowserve CLO Acquires Shares via Employee Stock Purchase Plan

A Form 4 filed on September 1, 2026 reports that Susan Claire Hudson, Chief Legal Officer of Flowserve Corp, acquired 31 shares of common stock through the company's 2024 Employee Stock Purchase Plan.

Nitish Kishor | 01 September 2026

Insight Enterprises Director Converts 217 RSUs to Common Stock

Director Thomas Reichert of Insight Enterprises Inc filed a Form 4 with the SEC on September 1, 2026, reporting the conversion of 217 restricted stock units into 217 shares of common stock on August 30, 2026.

Anjali Anand | 01 September 2026

Insight Enterprises Director Foutty Files Form 4 on RSU Vesting

Director Janet Foutty filed a Form 4 with the SEC on September 1, 2026, disclosing the vesting and acquisition of 217 shares of Insight Enterprises common stock through the conversion of restricted stock units on August 30, 2026.

Manish Choudhary | 01 September 2026

Crinetics Director Disposes All Shares in Vertex Merger

Director Stephanie Okey filed a Form 4 with the SEC on September 1, 2026, reporting the disposition of all directly held common stock, restricted stock units, and stock options in Crinetics Pharmaceuticals, Inc. following the completion of a merger with Vertex Pharmaceuticals Incorporated.

Manish Choudhary | 01 September 2026

Insight Enterprises General Counsel Sells 248 Shares

A Form 4 filed on September 1, 2026, discloses that Karim Adatia, General Counsel of Insight Enterprises Inc, disposed of 248 shares of common stock on August 28, 2026.

Nitish Kishor | 01 September 2026

Crinetics Director Disposes of Shares and Options in Merger

Director Rogerio Vivaldi Coelho filed a Form 4 with the SEC on September 1, 2026, disclosing the cancellation of common stock, restricted stock units, and stock options in connection with the merger of Crinetics Pharmaceuticals, Inc. into a subsidiary of Vertex Pharmaceuticals Incorporated.

Anjali Anand | 01 September 2026

Crinetics Director Reports Share Disposals After Merger

Director Wendell Wierenga filed a Form 4 with the SEC on September 1, 2026, reporting the cancellation of common stock, restricted stock units, and stock options in connection with Crinetics Pharmaceuticals, Inc.'s merger with a subsidiary of Vertex Pharmaceuticals Incorporated.

Aakashdeep | 01 September 2026

Concentra Director Sells 1 Million Shares in Stock Repurchase

Robert A. Ortenzio, a director of Concentra Group Holdings Parent, Inc. (NYSE:CON), filed an amended ownership statement on September 1, 2026, disclosing the sale of an aggregate of 1,000,000 shares of common stock to the company on August 21, 2026, pursuant to a Stock …

Aakashdeep | 01 September 2026

Mastercard Chief Services Officer Sells 923 Shares

Linda Kirkpatrick Pistecchia, Chief Services Officer of Mastercard Inc, filed a Form 4 on September 1, 2026, disclosing the sale of 923 shares of Class A Common Stock on August 31, 2026, under a pre-established Rule 10b5-1 trading plan.

Anjali Anand | 01 September 2026

Visa General Counsel Sells 2,028 Shares Under 10b5-1 Plan

Julie B. Rottenberg, General Counsel of Visa Inc. (NYSE:V), filed a Form 4 on September 1, 2026, disclosing the exercise of employee stock options and the same-day sale of 2,028 shares of Class A Common Stock on August 31, 2026, pursuant to a Rule …

Shwetambri Chauhan | 01 September 2026
Support

Hi! How can we help you today?

Loading…